1. Murai, Junko, Pommier, Yves. . BRCAness, Homologous Recombination Deficiencies, and Synthetic Lethality. In Cancer research, 83, 1173-1174. doi:10.1158/0008-5472.CAN-23-0628. https://pubmed.ncbi.nlm.nih.gov/37057596/
2. Grunnet, Mie, Calatayud, Dan, Schultz, Nicolai A A, Brünner, Nils, Stenvang, Jan. 2015. TOP1 gene copy numbers are increased in cancers of the bile duct and pancreas. In Scandinavian journal of gastroenterology, 50, 485-94. doi:10.3109/00365521.2014.980318. https://pubmed.ncbi.nlm.nih.gov/25615400/
3. Rømer, Maria Unni, Jensen, Niels Frank, Nielsen, Signe Lykke, Nielsen, Hans Jørgen, Brünner, Nils. . TOP1 gene copy numbers in colorectal cancer samples and cell lines and their association to in vitro drug sensitivity. In Scandinavian journal of gastroenterology, 47, 68-79. doi:10.3109/00365521.2011.638393. https://pubmed.ncbi.nlm.nih.gov/22171973/
4. Lin, Peter, Lourenco, Corey, Cruickshank, Jennifer, Moffat, Jason, Penn, Linda Z. . Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality. In Cancer research, 83, 4015-4029. doi:10.1158/0008-5472.CAN-22-2948. https://pubmed.ncbi.nlm.nih.gov/37987734/
5. Ho, Jessica Sook Yuin, Mok, Bobo Wing-Yee, Campisi, Laura, Richt, Juergen A, Marazzi, Ivan. 2021. TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. In Cell, 184, 2618-2632.e17. doi:10.1016/j.cell.2021.03.051. https://pubmed.ncbi.nlm.nih.gov/33836156/
智鼠故事 
